MyFinsight
Home
Blog
About
Proceeds from exercise of
partner company's...
$158K
Proceeds from issuance of
common stock under espp
$74K
(72.09%↑ Y/Y)
Net cash provided by
(used in) financing...
$91K
(-99.84%↓ Y/Y)
Canceled cashflow
$141K
Net increase in cash
and cash...
-$59,265K
(-452.96%↓ Y/Y)
Canceled cashflow
$91K
Stock-based compensation
expense
$2,878K
(-87.53%↓ Y/Y)
Inventory
-$1,136K
(28.06%↑ Y/Y)
Amortization of acquired
intangible assets
$969K
Prepaid expenses and
other current assets
-$958K
(59.32%↑ Y/Y)
Net income (loss)
$602K
Reduction in the carrying
amount of operating...
$465K
(-52.11%↓ Y/Y)
Other long-term
liabilities
$340K
(-26.72%↓ Y/Y)
Amortization of debt discount
$223K
(-70.11%↓ Y/Y)
Depreciation expense
$94K
(-56.88%↓ Y/Y)
Other receivables -
related party
-$10K
(-102.58%↓ Y/Y)
Proceeds from partner
companies' at-the-market...
-$141K
(-102.09%↓ Y/Y)
Net cash provided by
(used in) operating...
-$59,277K
(-25.79%↓ Y/Y)
Canceled cashflow
$7,675K
Net cash (used in)
provided by investing...
-$79K
(-101.09%↓ Y/Y)
Accounts payable and
accrued expenses
-$43,628K
(-457.83%↓ Y/Y)
Accounts receivable
$11,243K
(117.59%↑ Y/Y)
Change in fair value of
investment
$10,744K
Lease liabilities
-$535K
(52.44%↑ Y/Y)
Other assets
$437K
(249.66%↑ Y/Y)
Income taxes payable
-$239K
(-559.62%↓ Y/Y)
Gain from
deconsolidation of subsidiary
$82K
Settlement of partner
company payables
-$33K
(95.85%↑ Y/Y)
Bad debt expense
-$11K
(95.53%↑ Y/Y)
Purchase of property and
equipment
$79K
Back
Back
Cash Flow
Fortress Biotech, Inc. (FBIO)
Fortress Biotech, Inc. (FBIO)
source: myfinsight.com